167 related articles for article (PubMed ID: 27537583)
21. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.
Wright JD; Matsuo K; Huang Y; Tergas AI; Hou JY; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL
Obstet Gynecol; 2019 Jul; 134(1):49-57. PubMed ID: 31188324
[TBL] [Abstract][Full Text] [Related]
23. Adenocarcinoma histology is a poor prognostic factor in locally advanced cervical cancer.
Jonska-Gmyrek J; Gmyrek L; Zolciak-Siwinska A; Kowalska M; Kotowicz B
Curr Med Res Opin; 2019 Apr; 35(4):595-601. PubMed ID: 30019594
[TBL] [Abstract][Full Text] [Related]
24. Screening patterns within organized programs and survival of Italian women with invasive cervical cancer.
Zucchetto A; Ronco G; Giorgi Rossi P; Zappa M; Ferretti S; Franzo A; Falcini F; Visioli CB; Zanetti R; Biavati P; La Rosa F; Baracco S; Federico M; Campari C; De Togni A; Piffer S; Pannozzo F; Fusco M; Michiara M; Castaing M; Seghini P; Tisano F; Serraino D;
Prev Med; 2013 Sep; 57(3):220-6. PubMed ID: 23732239
[TBL] [Abstract][Full Text] [Related]
25. Trend and survival outcome in Taiwan cervical cancer patients: A population-based study.
Kau YC; Liu FC; Kuo CF; Huang HJ; Li AH; Hsieh MY; Yu HP
Medicine (Baltimore); 2019 Mar; 98(11):e14848. PubMed ID: 30882680
[TBL] [Abstract][Full Text] [Related]
26. Recurrence, death risk, and related factors in patients with stage 0 colorectal cancer: A nationwide population-based study.
Hsieh MH; Kung PT; Kuo WY; Ke TW; Tsai WC
Medicine (Baltimore); 2020 Sep; 99(36):e21688. PubMed ID: 32899000
[TBL] [Abstract][Full Text] [Related]
27. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
[TBL] [Abstract][Full Text] [Related]
28. Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis.
Wu SG; Zhang WW; Sun JY; Li FY; He ZY; Zhou J
Int J Surg; 2017 Dec; 48():122-127. PubMed ID: 29032160
[TBL] [Abstract][Full Text] [Related]
29. Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study.
Taarnhøj GA; Christensen IJ; Lajer H; Fuglsang K; Jeppesen MM; Kahr HS; Høgdall C
Cancer; 2018 Mar; 124(5):943-951. PubMed ID: 29211304
[TBL] [Abstract][Full Text] [Related]
30. Cervical cancer practice patterns and appropriateness of therapy.
Howell E; Chen YT; Moradi M; Concato J
Am J Obstet Gynecol; 2000 Aug; 183(2):407-13. PubMed ID: 10942478
[TBL] [Abstract][Full Text] [Related]
31. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
32. Survival analysis of Stage IIA1 and IIA2 cervical cancer patients.
Lai JC; Chou YJ; Huang N; Tsai JJ; Huang SM; Yang YC; Chang CL; Wang KL
Taiwan J Obstet Gynecol; 2013 Mar; 52(1):33-8. PubMed ID: 23548215
[TBL] [Abstract][Full Text] [Related]
33. Characteristics, survival, and related factors of newly diagnosed colorectal cancer patients refusing cancer treatments under a universal health insurance program.
Liu CY; Chen WT; Kung PT; Chiu CF; Wang YH; Shieh SH; Tsai WC
BMC Cancer; 2014 Jun; 14():446. PubMed ID: 24938667
[TBL] [Abstract][Full Text] [Related]
34. Predictors of Survival in Patients With FIGO Stage IVB Cervical Cancer.
Sasano T; Mabuchi S; Kuroda H; Takahashi R; Kozasa K; Isohashi F; Yoshioka Y; Ogawa K; Kimura T
Int J Gynecol Cancer; 2016 Mar; 26(3):528-33. PubMed ID: 26825839
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of cervical cancer in Taiwan.
Wang PD; Lin RS
Gynecol Oncol; 1996 Sep; 62(3):344-52. PubMed ID: 8812531
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and survival of cervical cancer in the French West-Indies: data from the Martinique Cancer Registry (2002-2011).
Melan K; Janky E; Macni J; Ulric-Gervaise S; Dorival MJ; Veronique-Baudin J; Joachim C
Glob Health Action; 2017; 10(1):1337341. PubMed ID: 28649938
[TBL] [Abstract][Full Text] [Related]
37. Incidence, mortality and survival from invasive cervical cancer in Vaud, Switzerland, 1974-1991.
Levi F; La Vecchia C; Randimbison L; Te VC
Ann Oncol; 1994 Oct; 5(8):747-52. PubMed ID: 7826908
[TBL] [Abstract][Full Text] [Related]
38. A population-based study of the influence of socioeconomic status on prostate cancer diagnosis in Taiwan.
Wu CC; Lin CH; Chiang HS; Tang MJ
Int J Equity Health; 2018 Jun; 17(1):79. PubMed ID: 29903010
[TBL] [Abstract][Full Text] [Related]
39. Influence of the time interval from diagnosis to treatment on survival for early-stage liver cancer.
Tsai WC; Kung PT; Wang YH; Kuo WY; Li YH
PLoS One; 2018; 13(6):e0199532. PubMed ID: 29933395
[TBL] [Abstract][Full Text] [Related]
40. Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival?
Garg G; Shah JP; Toy EP; Christensen C; Deppe G; Asaad R; Morris RT
Int J Gynecol Cancer; 2011 May; 21(4):711-6. PubMed ID: 21412165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
